×
About 3,638 results

ALLMedicine™ Intestinal Obstruction Center

Research & Reviews  1,181 results

The Emergency Surgery Frailty Index (EmSFI) in Elderly Patients with Acute Appendicitis...
https://doi.org/10.1007/s00268-023-06975-w
World Journal of Surgery; Fusario D, Neri A et. al.

Mar 23rd, 2023 - Identification of reliable risk-stratification tools is critical for surgical decision making, particularly in frail and elderly. The aim of the study is to validate the Emergency Surgery Frailty Index (EmSFI), in over 65 years old patients operat...

Short-Bowel Syndrome
https://emedicine.medscape.com/article/193391-print

Mar 16th, 2023 - Practice Essentials Each year in the United States, many patients undergo resection of long segments of small intestine for various disorders, including inflammatory bowel disease (IBD), malignancy, mesenteric ischemia, and others. Juvenile surviv...

Short-Bowel Syndrome
http://emedicine.medscape.com/article/193391-overview

Mar 16th, 2023 - Practice Essentials Each year in the United States, many patients undergo resection of long segments of small intestine for various disorders, including inflammatory bowel disease (IBD), malignancy, mesenteric ischemia, and others. Juvenile surviv...

Short-Bowel Syndrome
https://emedicine.medscape.com/article/193391-overview

Mar 16th, 2023 - Practice Essentials Each year in the United States, many patients undergo resection of long segments of small intestine for various disorders, including inflammatory bowel disease (IBD), malignancy, mesenteric ischemia, and others. Juvenile surviv...

Hypokalemia Treatment & Management
http://emedicine.medscape.com/article/242008-treatment

Mar 13th, 2023 - Approach Considerations The treatment of hypokalemia has four facets, as follows: Reduction of potassium losses Replenishment of potassium stores Evaluation for potential toxicities Determination of the cause to prevent future episodes, if possibl...

see more →

Guidelines  1 results

Removal of foreign bodies in the upper gastrointestinal tract in adults: European Socie...
https://doi.org/10.1055/s-0042-100456
Endoscopy Birk M, Bauerfeind P et. al.

Feb 11th, 2016 - This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). It addresses the removal of foreign bodies in the upper gastrointestinal tract in adults. Recommendations Nonendoscopic measures 1 ESGE recommend...

see more →

Drugs  69 results see all →

Clinicaltrials.gov  86 results

Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial
https://clinicaltrials.gov/ct2/show/NCT05755685

Mar 6th, 2023 - The goal of this study is planing to adopt intra-abdominal perfusion therapy of rmhTNF during radical colorectal cancer surgery to determine whether intra-abdominal therapy has an impact on postoperative intestinal function recovery, anastomotic l...

The Effect of Abdominal Massage Applied After Surgery
https://clinicaltrials.gov/ct2/show/NCT05750186

Mar 1st, 2023 - Gastrointestinal symptoms that cause discomfort in patients and reduce their quality of life and comfort include disorders related to the esophagus, stomach, duodenum, jejunum, ileum, large intestine, sigmoid colon and rectum. These symptoms: refl...

Band Adhesions in Relation to Previous Abdominal Surgery
https://clinicaltrials.gov/ct2/show/NCT03663023

Feb 24th, 2023 - Postoperative intra-abdominal adhesions are a common cause of small bowel obstruction. The extent of adhesions has been assigned to the magnitude of previous surgery. In a county hospital, with a catchment population of 120 000 inhabitants, record...

Prevention of Opioid-induced Constipation in Patients With Metastatic or Locally Advanced Incurable Cancer
https://clinicaltrials.gov/ct2/show/NCT05216328

Feb 14th, 2023 - More than 70% of patients with cancer in the palliative phase have pain that often requires treatment with opioids (morphine-like agents). Constipation occurs in 59% of patients treated with opioids. Opioid-induced constipation (OIC) has consequen...

Preemer Trial - Prophylactic Mesh Versus no Mesh in the Midline Emergency Laparotomy Closure for Prevention of Incisional Hernia: a Multi Center, Double-blind, Randomized Controlled Trial
https://clinicaltrials.gov/ct2/show/NCT04311788

Feb 6th, 2023 - Incisional hernia (IH) is a common complication of abdominal wall surgery. Its' incidence varies greatly (2-30 %) among studies. The incisional hernia incidence is influenced by several factors, such as closing technique, follow-up time and the mo...

see more →

News  99 results

FDA OKs First Targeted Treatment for HER2-Positive Colorectal Cancer
https://www.medpagetoday.com/hematologyoncology/coloncancer/102708

Jan 19th, 2023 - The FDA has granted accelerated approval to tucatinib (Tukysa) in combination with trastuzumab (Herceptin) for adult patients with RAS wild-type, HER2-positive unresectable or metastatic colorectal cancer who have progressed following treatment wi...

High Response Rate With Neoadjuvant Anti-PD-1 in Localized dMMR Colorectal Cancer
https://www.medpagetoday.com/hematologyoncology/coloncancer/102615

Jan 12th, 2023 - Neoadjuvant immunotherapy with PD-1 inhibitors led to objective responses in 85% of patients with localized and locally advanced colorectal cancer (CRC) with mismatch repair deficiency (dMMR)/high microsatellite instability (MSI-H), a retrospectiv...

FDA Approves Mirvetuximab Soravtansine-gynx for FRα+ Platinum-resistant Ovarian Cancer
https://www.onclive.com/view/fda-approves-mirvetuximab-soravtansine-gynx-for-fr-platinum-resistant-ovarian-cancer

Nov 17th, 2022 - The FDA has granted accelerated approval to mirvetuximab soravtansine-gynx (Elahere) for the treatment of adult patients with folate receptor α (Frα)–positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, wh...

FDA Approves First IHC Companion Diagnostic for Mirvetuximab Soravtansine in Ovarian Cancer
https://www.onclive.com/view/fda-approves-first-ihc-companion-diagnostic-for-mirvetuximab-soravtansine-in-ovarian-cancer

Nov 15th, 2022 - The FDA has approved the VENTANA FOLR1 (FOLR1-2.1) RxDx assay, the first immunohistochemistry (IHC) companion diagnostic test to help identify patients with epithelial ovarian cancer who are eligible for treatment with mirvetuximab soravtansine-gy...

Trilaciclib Reduces Sacituzumab Govitecan–Related AEs in Locally Advanced or Metastatic TNBC
https://www.onclive.com/view/trilaciclib-reduces-sacituzumab-govitecan-related-aes-in-locally-advanced-or-metastatic-tnbc

Nov 2nd, 2022 - The administration of trilaciclib (Cosela) prior to treatment with sacituzumab govitecan-hziy (Trodelvy) meaningfully reduced adverse effects (AEs) related to the antibody-drug conjugate (ADC) in patients with unresectable locally advanced or meta...

see more →

Patient Education  19 results see all →